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Monitoring gene expression is an important tool for elucidating mechanisms of
cellular function. In order to monitor gene expression during nerve cell development,
molecular beacon (MB) probes targeting markers representing different stages of
neuronal differentiation were designed and synthesized as 2’-O-methyl RNA backbone
oligonucleotides. MBs were transfected into human mesencephalic cells (LUHMES) using
streptolysin-O-based membrane permeabilization. Mathematical modeling, simulations
and experiments indicated that MB concentration was equal to the MB in the transfection
medium after 10min transfection. The cells will then each contain about 60,000 MBs.
Gene expression was detected at different time points using fluorescence microscopy.
Nestin and NeuN mRNA were expressed in approximately 35% of the LUHMES cells
grown in growth medium, and in 80–90% of cells after differentiation. MAP2 and tyrosine
hydroxylase mRNAs were expressed 2 and 3 days post induction of differentiation,
respectively. Oct 4 was not detected with MB in these cells and signal was not increased
over time suggesting that MB are generally stable inside the cells. The gene expression
changes measured using MBs were confirmed using qRT-PCR. These results suggest
that MBs are simple to use sensors inside living cell, and particularly useful for studying
dynamic gene expression in heterogeneous cell populations.
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INTRODUCTION
The ability to detect mRNAs in individual live cells allows inves-
tigators to exactly pinpoint when a gene is turned on and
off in response to a stimulus. Detecting and measuring gene
expression has traditionally been limited to the use of technolo-
gies such as DNA microarrays, reverse-transcription polymerase
chain reaction (RT-PCR), northern blotting, and fluorescence in
situ hybridization (FISH), all of which examine the gene expres-
sion in lysed or chemically-fixed cell populations. In contrast
to these destructive methods, green fluorescent protein label-
ing (GFP) can be used to track gene expression in living cells.
However, GFP and other similar reporter systems cannot measure
endogenous mRNA expression in living cells but rely on fusing
the GFP gene to the promoter region of interest. GFP/promoter
constructs might be integrated into the host genome or be tran-
siently transfected as non-integrating plasmids. Furthermore, the
GFP gene and its products (mRNA and proteins, respectively) are
not necessarily processed in the same way as the native gene and
its products, which can lead to errors in measurement (Lee et al.,
2006; Dobek et al., 2011).
Molecular beacon technology was first described in Tyagi and
Kramer (1996). Molecular beacons (MBs) are stem-loop form-
ing oligonucleotides with a fluorochrome on one end, and a
quencher on the other end. MB recognize its target through
the loop and when hybridized displaces the quencher from the
fluorochrome. The MBs enables one-step detection of specific
nucleic acids in homogeneous solutions (Tyagi and Kramer,
1996). Theoretically, this makes MBs an ideally suitable tool for
monitoring gene expression inside living cells on the mRNA level.
Despite that, there are far fewer reports describing the use of
MBs for monitoring gene expression in living cells compared to
the number of reports describing usage of GFP labeling. Bratu
et al. (2003) used MBs to visualize the distribution and trans-
port of oskar mRNA in Drosophila oocytes. Santangelo et al.
(2004) used MBs to analyze the distribution and transport of
mRNA in intracellular organelles, and demonstrated that both
mRNAs for GAPDH and K-Ras were localized in the mitochon-
dria. The combination of protein detection with antibodies and
mRNA detection with MBs has been used to detect and isolate
rare cancer stem cells from populations of normal cells, using
fluorescence activated cell sorting (Rhee and Bao, 2009). MBs tar-
geting the OCT4 mRNA, which is highly expressed in embryonic
and cancer stem cells, were introduced into mouse carcinoma cell
line without affecting cell function. The MB toward OCT4 was
used to discriminate between undifferentiated and retinoic acid-
differentiated cells (Rhee and Bao, 2009). MBs targeting SOX2
mRNA were used as the sole discriminator to sort mouse embry-
onic and neural stem cells (Larsson et al., 2012). The isolated
SOX2 mRNA-positive cells formed neurospheres more efficiently
than SOX2 mRNA-negative cells. The clinical and diagnostic util-
ity of MBs was demonstrated in a feasibility study on bladder
cancer (Zhao et al., 2010), in which MBs were used to detect sur-
vivin mRNA. However, the MB-based assay produced some false
positive results, which compromised its immediate use for routine
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diagnosis. MBs have also been used to monitor expression of two
microRNAs (miR-26a and miR-206) during myogenesis (Kang
et al., 2011). This study used two MBs with different dyes and
quenchers, allowing simultaneous visualization of both miRNAs
during myogenesis. Real-time changes in β1-integrin expression
in osteoblasts in response to surface modification were tracked
with MBs over short periods of time; this study was particularly
powerful since changes in mRNA localization were visualized in
the same live cells (Lennon et al., 2010). Finally, MBs were used
to monitor the temporal gene expression of osteogenic markers,
including alkaline phosphatase, type I collagen and osteocalcin
during differentiation of adipose-derived stem cells (Desai et al.,
2013).
In contrast to hybridization in solution where the physic-
ochemical conditions are simplified, hybridization of MBs to
mRNA in living cells is complicated by the formation of sec-
ondary structures in the mRNA molecules, RNA-binding pro-
teins, and the degradation of the probes due to enzymes with
nuclease activity (Rhee et al., 2008). Software programs such as
mFOLD and Beacon Designer can predict the formation of sec-
ondary structures so that these sequences can be avoided during
the selection of probes in the design process. The prediction of
protein binding sites in the target is more complicated due to only
limited data existing for RNA-binding proteins (Rhee et al., 2008).
Competition with RNA or RNA-binding proteins can result in a
significant decrease in signal level due to inefficient hybridization
between the MB and the target sequence. To overcome this, many
studies have used 2′-O-methyl RNA MBs in order to increase
the affinity for the target mRNA (Tsourkas et al., 2002). In addi-
tion, a modified backbone is less vulnerable to nuclease activity.
However, the formation of double-stranded RNA can lead to
RNA silencing, and therefore influence cellular function. Others
(Lennon et al., 2010; Desai et al., 2013) have successfully used
DNA based MBs in living cell studies even though it has been
reported that DNA based MBs can be degraded and give false
positive signals, particularly if the MBs are going into the nucleus
(Chen et al., 2007).
From the review above, it is clear that the usage of MB have
several advantages over GFP. For instance, cloning, genome incor-
poration and/or genomic gene replacements are not needed.
Furthermore, MB allows for endogenous transcripts to be
measured. As opposed to quantitative reverse transcription poly-
merase chain reaction (qRT-PCR), MB technology is non-
destructive allowing for time course studies on the same cell
population or culture. However, MBs needs to be developed and
tested for each specific gene and as opposed to qRT-PCRmethods,
there are relatively few MB that has been described to work inside
living cells. The aim of this work was to demonstrate the useful-
ness of MBs to detect dynamic changes in gene expression during
differentiation of stem cells into the neural lineage. We designed
and used MBs toward OCT4, SOX2 (Ilieva and Dufva, 2013),
NeuN, MAP2, Nestin, and tyrosine hydroxylase (TH) mRNAs
to track neural stem cell progression from neuronal progeni-
tors, via mature neurons, into highly specialized neurons. Time
lapse imaging of growing and differentiating cells allowed us to
determine the differentiation status of each cell in the population
throughout a 7-day experiment.
MATERIALS AND METHODS
CELL CULTURE AND MEDIA
LUHMES (Lund human mesencephalic cell line, ATCC, CRL-
2927) are a subclone of the tetracycline-controlled, v-myc-
overexpressing humanmesencephalic-derived cell lineMESC2.10
immortalized with a LINX v-myc retroviral vector, as described
by Lotharius et al. (2002). These cells possess robust dopaminer-
gic characteristics (Lotharius et al., 2005). Undifferentiated cells
were cultured and expanded in cell culture flasks pre-coated with
Geltrex®, which is a reduced growth factor basement membrane
extract purified from murine Engelbreth-Holm-Swarm tumor
(Invitrogen). The flasks were coated by incubating for 1 h at 37◦C
with Geltrex® diluted 1:100 in phosphate buffered saline (PBS).
Cultures were maintained in growth medium (GM), consisting
of advanced DMEM/F12 (Sigma), 1× N2 supplement (Gibco),
2mM L-glutamine, 1% penicillin/streptomycin, and 40 ng/ml
recombinant basic fibroblast growth factor (bFGF; Invitrogen).
Cells were maintained at 37◦C in a humidified atmosphere with
5% CO2.
HeLa Tet-On® Advanced cells (631155, Clontech) were cul-
tured in DMEM/F12 supplemented with 10% fetal bovine serum
(FBS), penicillin 100 U/ml and streptomycin 100μg/ml.
DIFFERENTIATION OF LUHMES
The differentiation process was initiated by adding differentiation
medium (DM) consisting of advanced DMEM/F12, 1x N2 sup-
plement, 2mM L-glutamine, 1mM dbcAMP (Sigma), 1μg/ml
tetracycline (Sigma), and 2 ng/ml recombinant human glial cell-
derived neurotrophic factor (GDNF; R&D Systems).
DESIGN OF MOLECULAR BEACONS
mRNA-targeting MBs were designed using Beacon Designer 7.9
(Premier Biosoft). The target sequence for each MB was ana-
lyzed using Human Genome BLAST (http://blast.ncbi.nlm.nih.
gov/Blast.cgi) to minimize the risk of non-specific binding to
unrelated mRNA. Regions not satisfying both the E-value and
the percentage identity criteria (the percentage of identical bases
between query and subject sequence in an alignment, default = 98
for the human genome) were avoided.
It is important to design the MB in an area of the target
with minimal secondary structure formation. This helps prevent
the template from preferentially annealing to itself faster than to
the MB. The program identified and avoided template sequence
predicted to give rise to significant secondary structures.
The parameters for MB design were set to ensure that the
search succeeded in finding the best possible sequence. The length
of the MBs was between 18 and 30 bp. The melting tempera-
ture (Tm) values of the probes were calculated using the nearest
neighbor thermodynamic calculation with Santa Lucia values
(SantaLucia, 1998). The parameters were set as follows: hair-
pin maximum dG (the free energy of the most stable alternate
hairpin that is acceptable) 4-kcal/mol; self-dimer maximum dG
(the free energy of the most stable self-dimer that is accept-
able) 7-kcal/mol; cross-dimer maximum dG (the free energy of
the most stable cross-dimer that is acceptable in a multiplex
reaction) 7-kcal/mol; run/repeat maximum 5 bp/dinucleotide
probes with single (e.g., AAAAA) runs or dinucleotide (e.g.,
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ATATATATAT) repeats of length greater than the specified value
were discarded. After selecting a probe sequence, two comple-
mentary arm sequences were added, one on each side of the probe
sequence. The stem region of the MBs was 5 bp long, with a CG
content of 80%.
All calculations performed with this program used the fol-
lowing default conditions: temperature for beacon free energy
calculation 55◦C, monovalent ion concentration 100mM, free
Mg2+concentration 3mM, and target concentration 250 nM.
For the MB probe search, the quality of the designed probe
is displayed as “best” (rating greater or equal to 75), “good”
(rating between 74 and 50), “poor” (rating below 50), or “not
found.” Only MBs with a “best” rating were chosen for synthesis
and further evaluation. MBs were synthesized with a 2′-O-methyl
RNA backbone, Cy3 molecule attached to the 5’-end, and black
hole quencher 2 (BHQ-2) attached to the 3′-end (Eurofins MWG
Operon). The sequences of the MBs used in the study are listed
in Table 1. MBs were diluted in RNase/DNase free dH2O to yield
stock concentrations of 100μM, and stored at −20◦C.
MOLECULAR BEACON In vitro CHARACTERIZATION
Each MB was incubated in 1x PBS at final concentration
0.5μM. The temperature was ramped from 20 to 90◦C with
steps of 0.3◦C and the fluorescence was measured at every
step after 5min on Chromo4 Real-Time Detection system
(BioRad). The melting temperature for each beacon was cal-
culated using the software OligoAnalyzer (http://eu.idtdna.
com/analyzer/Applications/OligoAnalyzer/27) and experimen-
tally estimated from the melting curve (data not shown). The
maximal signal intensity and signal to noise ratio of 2′O-methyl
molecular beacons (MBs) were tested against complementary
DNA targets. 0.5μM of the respective MB and equal concen-
tration of the respective complementary target in 1x PBS was
incubated at 37◦C. The fluorescence emission was inspected every
5 s for the first 2min, then every 2min for 10min and finally every
15min for 3 h.
TOXIN-BASED MEMBRANE PERMEABILIZATION
MBs were introduced into the cytoplasm of living cells using
toxin-based membrane permeabilization using streptolysin-O
(SLO, Sigma), which is a bacterial exotoxin that reversibly
forms pores in the cell surface (Chen et al., 2011). SLO at a
concentration 1μg/ml was activated with the reducing agent
tris(2-carboxyethyl)phosphine hydrochloride solution (TCEP,
Sigma), at a final concentration 5mM in Dulbecco’s PBS (DPBS)
for at least 30min at 37◦C. Cells were washed with DPBS without
Ca2+ and Mg2+, trypsinized for 3min at 37◦C, and collected by
centrifugation for 5min at 190× g. The activated SLOwas diluted
in serum free medium (Opti-MEM) to concentrations between 1
and 800 ng/ml, and mixed with MB (2μM final concentration).
Cells (1 × 105) were incubated with the SLO/MB mixture in a
final volume of 100μl in Opti-MEM for approximately 15min.
Afterwards, the permeabilized cells were resealed by washing in
DPBS containing Ca2+and Mg2+, collected by centrifugation for
5min at 190 × g, and plated in 12-well plates pre-coated with
Geltrex® and containing GM. The differentiation process was
started 24 h after plating by exchanging GM for DM.
HeLa cells were transfected as a monolayer with 230 ng/ml (17
U/ml) activated SLO in Opti-MEM. Cells (1 × 105) were washed
three times with pre-warmed DPBS and incubated with toxin and
MB (2μM final concentration) in 200μl Opti-MEM for 15min.
Cells were washed three times with DPBS containing Ca2+and
Mg2+ and were kept in growth medium.
DETECTION OF CELLULAR VIABILITY
Cellular viability was detected using calcein-propidium iodide
staining. Twenty-four hours after SLO treatment without MB
medium from each well was carefully removed and cells were
incubated for 30min with 3μM calcein AM (live cell dye) and
2.5μM propidium iodide (dead cell dye) diluted in warm 1×
DPBS without Ca2+and Mg2+.
IMAGING AND IMAGE ANALYSIS
Phase contrast and fluorescent images were acquired using a
Carl Zeiss Axio Vision 4.8.2 equipped with ApoTome Imaging
system, 40×/0.75 Plan-Neofluar objective, HXP lamp, and a
Zeiss Axiocam MRm B/W camera. The same exposure time and
filter set (43 HE Ds Red 538–570 nm) were used for all exper-
iments. Single-cell image analysis was performed using ImageJ
software (http://rsb.info.nih.gov/ij/). A region of interest (ROI)
was drawn around the cells and the total fluorescent inten-
sity (FI) measured. The background fluorescence was detected
by drawing a ROI in an area outside the cell of interest, and
the total FI measured. In ImageJ, the total fluorescence inten-
sity is reported as integrated density (ID), which is the sum
of the values of the pixels in the selection. The background
measurement of FI was subtracted from the cellular measure-
ment (Chen et al., 2011). Cells expressing the gene of interest
were calculated as the number of cells with positive fluores-
cent signal emitted from each specific MB per 100 counted
cells.
Table 1 | Molecular beacon sequences.
Molecular beacon Sequence GenBank numbers
Nestin CGCUCUCUCACUACCUCCACAUCCUUGAGCG NM_006617
NeuN CGCUCUCCCAUUCAGCUUCUCCCGGAGCG NM_001082575.1
MAP2 CGCUCGUUGUCUCUGGCUGAGAAACUAAGAGCG NM_002374.3
TH CGCUCACACCUUCACAGCUCGGGAGAGCG NM_199292.2
OCT4 CGCUCUCAUUCACCCAUUCCCUGUUGAGCG NM_203289
SOX2 CGCUCCGCCGCCGAUGAUUGUUAUUAUGAGCG NM_003106.3
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QUANTITATIVE POLYMERASE CHAIN REACTION
Total RNA was isolated from cultured cells using the RNeasy
Mini Kit (Qiagen). Cells were lysed directly on the dish. The
lysates were collected and purified according to the manufac-
turer’s instructions. Single-stranded cDNA was prepared from
total RNA using random RT primers under standard conditions
using MultiScribe Reverse Transcriptase (Applied Biosystems).
The cDNA from each sample was diluted and used for real-time
PCR analysis for quantification of neuronal marker expression.
TaqMan assays (Invitrogen) for target genes were used as fol-
lows: OCT4 (ID Hs04260367_gH), SOX2 (ID Hs01053049_s1),
Nestin (ID Hs00707120_s1), MAP2 (ID Hs00258900_m1), NeuN
(RBFOX3 ID Hs01370653_m1), TH (ID Hs00165941_m1) with
GAPDH (ID Hs03929097_g1) as an internal positive control.
PCR amplifications were performed in duplicate using the
Chromo4 Real-Time Detection system (BioRad) at 95◦C for 10 s,
followed by 40 cycles of 95◦C for 5 s and 60◦C for 30 s. To
quantify the relative expression of each gene, the Ct (threshold
cycle) values were normalized to the Ct value of GAPDH [e.g.,
Ct = Ct(target)—Ct(GAPDH)]. All experiments included neg-
ative controls containing no cDNA template.
STATISTICAL ANALYSIS
Results are expressed as mean ± standard error of the mean
(s.e.m). qPCR was analyzed using a Mann-Whitney test (n = 5).
Analyses were performed using XLSTAT Version 2013.5.07
(Addinsoft).
DIFFUSION OF MB OUT OF THE CELLS
The adherent cell line HeLa was transfected with MB toward TH
using the SLO. This particular MB did not contain a quencher
and was thus always fluorescent even when the MBs are in the
closed state. The pores were closed after transfection by washing
three times with DPBS containing Ca2+andMg2+, and incubated
for 1 h to let cells recover in growth medium. Hybridization was
not expected because TH is not expressed in this particular cell
line. The cells were fluorescent as expected and had their normal
morphology (data not shown) after transfection. At this point the
cells were again treated with SLO reagent to re-open the pores
and the fluorescent decay from the cells was monitored by time
laps microscopy for 20min.
RESULTS
INTRODUCTION OF MBs INTO CELLS
Cell viability and transfection efficiency were investigated as
a function of SLO concentration ranging from 1 ng/mL (cor-
responding to 0.07U/mL) to 800 ng/mL (corresponding to
59.7 U/mL). Undifferentiated LUHMES cells that express SOX2
but not OCT4 mRNA (Ilieva and Dufva, 2013) were used
in the optimization. An SLO concentration of 17 U/mL
was determined to be the optimal concentration, with near
95% of the cells showing signal from MB targeting SOX2
24 h post-transfection (Figure 1), and with >95% cell viabil-
ity after SLO treatment (Supplementary Figure S1A). OCT4
mRNA was not expressed (Figure 1). Moreover, cells showed
no defects in growth or differentiation and they exhib-
ited the same morphology as non-transfected cells (untrans-
fected cells are shown in Supplementary Figure S1B, and
transfected cells in Figure 4). An SLO concentration of
17U/mL (230 ng/mL) was therefore used in the further
experiments.
For analytical purposes, it is of utmost importance to have an
estimate of the number of MB that enters cells during transfec-
tion. The SLO process opens pores during the transfection and
then the MB enters the cells by diffusion. This transfection mech-
anism will yield a maximum intracellular concentration of MB
that is equal to the MB concentration outside the cells (in this
case 2μM).
The time it takes to reach maximum concentration inside cells
was measured experimentally and estimated theoretically in order
to ensure that this maximum concentration could be reached
during the 15-minute transfection.
FIGURE 1 | Fluorescent images of cells transfected with MBs
targeting stem cell markers SOX2 and OCT4. High transfection
eficiency was detected using SLO and ∼95% of cells shows to
be positive for SOX2 MB after 1 d in GM. Relatively the same
number of SOX2 positive cells was detected after 7 d
differentiation but with significant depletion in fluorescent intensity.
Signal from OCT4 MBs was not detect during the whole
experimental period.
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Direct experimental tracking the fluorescence during trans-
fection is difficult due to the high background from MBs in the
medium. Instead the decay of fluorescence from cells loaded with
MBs lacking a quencher was tracked. It took about 10min for all
MBs to leave the cells (Figure 2), which is less than the 15-min
transfection protocol.
A finite element model (FEM) and an analytical model (see
Supplementary information for details) of diffusion from the
FIGURE 2 | Fluorescence emission decay as a function of time for a
representative HeLa cell after the second treatment with SLO. The
resulting time constant is τexp = 198 s.
FIGURE 3 | The average concentration of MBs in the cell as a function
of transfection time. Results from a COMSOL FEM model (dots) are
compared to the analytical model (black line) with the time constant
τc = 9.6 s. The average concentration in the outdiffusion experiment
calculated from the analytic model is shown as the dashed curve using the
time constant τo = 19.3 s.
medium, through the pores and into the cells agree (Figure 3)
that it takes approximately 0.5min to reach maximum concen-
tration in the cells. This is faster than the experimental result,
but the models are very sensitive to the MB diffusivity, pore size,
and number of pores, parameters that are difficult to estimate
correctly (see Discussions).
Therefore it is likely that there are about 60,000 MB molecules
inside the cells after transfection (see Supplementary information
for example calculations). However, the number of MBs in the
cells is heavily dependent on the cytoplasmic volume compared
to the nuclear volume. A cytoplasmic volume of 20%, the cells
will each contain in 120,000 MBs after transfection while a cyto-
plasmic volume of 10%, the cells will each contain 60,000 MBs
after transfection. Bustin (2000) found that there are about 108
mRNA copies of GAPDH per microgram of total RNA. Assuming
that there is about 10 pg total RNA per cell (Bustin, 2000), there
would be about 1000 GAPDH mRNA copies per cell, indicating
that there is at least 50-fold more MB than possible target.
GENE EXPRESSION OF STEM CELL AND NEURONAL MARKERS
DETECTED BY MBs
MBs targeting mRNAs specific for stem cell (OCT4, SOX2) neu-
ral progenitors (Nestin), mature neurons (NeuN and MAP2), and
highly specialized neurons (TH) were designed (material and
methods). The function of the respective MB was evaluated by
hybridization to their respective perfect match target in 1 X PBS.
The fluorescence of the MB in hybridized state with the com-
plementary target vs. fluorescence of MB in unhybridized state
(signal to noise ratio) and maximal signal intensity of hybridized
MB were evaluated. The S/N ratio varied greatly and only MB-
OCT4 had low S/N ratio (OCT4 = 2, SOX2 = 23, TH = 47,
MAP2 = 10, nestin = 25, and NeuN = 13). However, the MB-
OCT4 probe has previously successfully been used to measure
OCT4 expression inside neurosphere formation of LUHMES cells
(Ilieva and Dufva, 2013). The maximum signals obtained from
the respective beacons also varied (in relative fluorescent units:
OCT4 = 7, SOX2 = 15, TH = 17,MAP2 = 19,Nestin = 29, and
NeuN = 10). Moreover, unhybridizedMBs had a measured melt-
ing point above 40◦C in 1XPBS (data not shown) which verified
that the MBs were functionally closed at physiological conditions.
The respective MBs targeting stem cell and neuronal mark-
ers were delivered into embryonic midbrain derived cell line
(LUHMES). The patterns of fluorescence signal emitted from cells
varied (Figure 4), and included small dotted signals (Figure 4A1),
more compact punctate signals (Figure 4A2), or widespread cyto-
plasmic cluster-like fluorescence (Figure 4A3). The last pattern
was more often observed in differentiated cells (Figures 4A4–6),
due to the compact cell body and tight perinuclear cytoplas-
mic organization. Non-differentiated cells showed signals in
the lamellipodia and cell body space (Figure 4A2), while dif-
ferentiated cells showed only cell body-localized MB signals
(Figures 4A4–6). All signal categories were included in the anal-
ysis when calculating the percentage of positive cells (see below).
Large bright signals were interpreted as false positives, as these
cells displayed dead cell morphology—reduced volume of the cell
body, irregular surface, often detached from the growth matrix
(Figure 4A7). Moreover, cells showing this morphology showed
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FIGURE 4 | Fluorescent images of cells transfected with MBs. (A).
Different MB signal patterns observed in LUHMES cells grown in GM 1 day
after transfection (A1–3) and 7 days post induction of differentiation (A4–6).
(A7) shows large bright fluorescent clusters originating from apoptotic cells
(artifact). These cells were excluded from calculations of the number of
positive cells and signal intensity. (B) Signals (red) from the respective
MBs—SOX2, nestin, NeuN, MAP2, TH from a population of cells. Please see
Supplementary information S2 outline of the experiments.
propidium iodide staining which is an indicator for dead cells
(data not shown). Therefore, these false positive signals were
excluded from the analysis.
Ninety-five percent of cells were positive for SOX2 mRNA
1d (1 day) post-transfection (Figures 1, 5). After 8d differentia-
tion, the same number of the cells was positive for SOX2 mRNA
(Figures 1, 5). By contrast OCT4 mRNA was not detected during
the whole experiment in any of the cells (Figures 1, 5). The rela-
tively poor ability of measuring down regulation of SOX2 mRNA
using the described SOX2 beacon has been discussed elsewhere
(Ilieva and Dufva, 2013) and explains why we do not see a large
drop in the number of SOX2 positive cells. Nestin, an intermedi-
ate filament protein expressed in dividing cells during the early
stages of development of the CNS, and nuclear protein antigen
(NeuN), were also detected 1d after transfection in about 35%
of cells (Figures 4B, 5). In contrast, no MAP2 and TH expres-
sion was detected in cells 1d post transfection (Figures 4B, 5).
Expression of MAP2 was detected in 30% of cells 2d post induc-
tion of differentiation (Figure 5), while the first TH-positive cells
appeared 3d post induction (Figure 5). The number of cells
expressing neuronal markers reached their maximum at different
time points as follows: 85% Nestin and NeuN-positive cells 5d,
85% MAP2-positive cells 6d, and 70% TH-positive cells 8d post
induction of differentiation, respectively. Signals from neuronal
markers NeuN and TH targeting MBs were not detected in the
control non-neural cell line—adipose-derived stem cells (ASC)
(Supplementary Figure S3). The intensity of the nestin-MB sig-
nal increased about two-fold compared to the point-of-induction
level. The maximum increase in Nestin-MB signal was observed
5d post induction. A slight decrease in the signal was detected
8d after induction (Figure 6). The maximal signal of NeuN was
observed 7d post induction (Figure 5). The MAP2-MB signal
maximized 5d post induction. TH-MB signal plateaued 4d post
induction. MAP2-MB signal intensity decreased slightly 8d post
induction, while TH levels remained constant (Figure 6).
CORRELATION BETWEEN qRT-PCR AND MB SIGNAL INTENSITIES
To corroborate the results using different MBs, qRT-PCR was
used to measure the respective mRNA expression before and 7
days after induction of differentiation. GAPDH was used as an
internal positive control. Expression of Nestin and NeuN was
detected in non-differentiated cells, and it significantly increased
after 7 days of differentiation (Figure 7). In contrast, expression
of the neuronal markers MAP2 and TH was not detected in non-
differentiated cells, but was later expressed, corroborating the
accuracy of the measurements made using MBs (Figures 3–5).
DISCUSSION
One significant advantage of in situ methodologies, and partic-
ularly MB technology, is the ability to gather spatial and tem-
poral data on biological phenomena of interest. There appears
to be single cell heterogeneity during neuronal differentiation of
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FIGURE 5 | The number of positive cells from MBs targeting OCT4,
SOX2, Nestin, NeuN, MAP2, and TH over time. Results from three
independent experiments are presented as mean ± standard error of the
mean (s.e.m).
FIGURE 6 | Relative signal for the respective MB. The fluorescence was
measured 1 day after transfection, and subsequently every day for 8 days of
differentiation. Results from three independent experiments are presented
as mean ± standard error of the mean (s.e.m).
a population of LUHMES. There were about 35% Nestin and
NeuN mRNA positive cells in non-differentiating cells. In con-
trast, 95% of the cells showed expression of SOX2 mRNA, which
indicates that there is a transfected population of cells that is
not expressing Nestin or NeuN. Alternatively, this subpopula-
tion of cells express Nestin and NeuN in too low concentra-
tions to be detected by the respective MB. Nestin is a nerve
stem cell marker found in proliferating cells which expression
is normally decreased during differentiation. However, Nestin
was expressed in equal level in non-differentiated LUHMES cells
FIGURE 7 | Analysis of mRNA expression levels of neuronal markers
using qRT-PCR in non-differentiated and differentiated LUHMES.
Expression was normalized to GAPDH mRNA expression. Data from five
independent experiments are expressed as mean ± s.e.m. ∗P < 0.05.
and a relatively pure population of differentiated LUHMES cells
(Scholz et al., 2011). Furthermore, Nestin was not down reg-
ulated during differentiation in some clones of human nerve
stem cells derived from ventral mesencephalon (Ramos-Moreno
et al., 2012). The data presented here using MBs (Figure 6)
and qRT-PCR (Figure 7) supports that Nestin is not down
regulated to large extent during differentiation of LUHMES
cells.
The heterogeneity of LUHMES cells is supported by previous
work where it was noted that some cells continue to prolifer-
ate to some extent during differentiation (Scholz et al., 2011).
These proliferating cells subsequently start to differentiate. Re-
plating of differentiating LUHMES cells at 2d results in 85–95%
cell with neuronal phenotype (Scholz et al., 2011) and without
re-plating>80% of the cells become TH positive (Lotharius et al.,
2002) indicating that the re-plating procedure removes proliferat-
ing cells (Scholz et al., 2011). In the present study re-plating was
not used which resulted in about 70% of the cells expressing TH
mRNA according to MB data.
Furthermore, here we report that the TH mRNA is expressed
at 3d after induction of differentiation with stable expression
from 4d. It was previously reported that TH protein expression in
LUHMES was detected at 4d (3d was not tested) after induction
of differentiation (Lotharius et al., 2002). NeuN protein expres-
sion increase during differentiation of LUHMES (Scholz et al.,
2011) with maximum expression levels at 5d post induction of
differentiation. The present study indicates that the NeuN mRNA
reached highest expression level at d7. Scholz et al. (2011) showed
that about 75% of the differentiating cells were positive for NeuN
protein at d5 while the present study showed that NeuN mRNA
was expressed in about 80% of the cells at d5. At day 0, how-
ever, we have conflicting results where the present study shows
that about 30% of the cells are positive for NeuN mRNA while
Scholz et al. (2011) showed that there was <1% NeuN protein
positive cells. It is, however, noteworthy that all these studies
typically do not show expression levels on the per day basis as
reported here (Figures 5, 6). The reason is likely that destructive
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analysis requires large number of parallel experiments to gather
information over time, which is costly and cumbersome. The
clear advantage of MBs is that they, like GFP technology, enable
non-destructive analysis of gene expression.
The MBs used in this study was made of 2-O-methyl RNA,
which avoids degradation of the MB with a resulting false pos-
itive signal. The mRNA signals in this study only appeared in
the cytoplasm indicating the fluorescent MB was reacting with
mRNA species. If MB where present in the nucleus is unknown
but no nucleic signal were observed indicating that MB were sta-
ble in the nucleus and did not bind unspecifically to DNA. The
specificity of each beacon in terms of hybridization to its intended
target inside cells is somewhat circumstantial but a few lines of
evidence indicate that these MBs are indeed specific. The MBs
reacted in vitro (test tubes) only with the perfect matched tar-
get and not to other synthetic targets (data not shown). The
beacons toward the neuronal markers did not result in signals
in all the transfected cells 1 day after transfection while fluores-
cent signals from SOX2 MB transfected cells were detected in
95% of the cells at the same time point. Moreover, the signal
from OCT4 MB was not detected throughout the experiment,
suggesting that the increase in the number of cells expressing
neuronal markers was due to binding to the respective com-
plementary target mRNA and not time depended unspecific
binding to mitochondria (Rhee and Bao, 2010) or nuclease diges-
tion. Finally, the control non-neural cell line ASC did not show
any signal from NeuN and TH MBs in the time where both
neuronal markers are already expressed in LUHMES, proving
target specificity of described MBs. It also suggest that modi-
fied MBs in general is not degraded inside the living cells (see
also Oct4 data in Figure 5). The MB signal for the neuronal
markers follows the same trend as q-RT-PCR data (Figures 5, 6)
and the expression pattern follows closely other reports (see
above). Furthermore, probe-target hybridization did not appear
to have any measurable effect on cell physiology including
gene expression, self-renewal, or differentiation (supplementary
Figures 1, 3).
The results here demonstrate that about 60000 MB loaded per
cell during the transfection. Transfection of SOX2-MB resulted
in ∼95% cell giving signals (Figures 4, 5) suggesting that the
vast majority of the cells received MBs. The amount of MB
transfected into the cells may, however, vary as a function of
number of pores formed and the speed, which they are formed.
Pore forming times between 10 and 300 s have been recorded
(Niedermeyer, 1985 and Palmer et al., 1998). There can therefore
be a delay before MB can enter the cells, which was not consid-
ered in the simulation and analytical solutions. The pores exhibit
a size distribution and 30 nm is considered an upper limit for
the diameter (Palmer et al., 1998). It is therefore possible that
smaller pores are formed, which would contribute to the expla-
nation of why the analytical (Figure 3) determined and measured
transport (Figure 2) did not overlap. It should be noted that dif-
ferentiating LUHMES leaves the cell cycle and decreases in signal
intensity due toMB dilution should therefore not be a large prob-
lem. At least a few cell divisions are allowed before any dilution
effect can be expected (Ilieva and Dufva, 2013). As estimated
above, there is on average a 50-fold excess of MBs to GAPDH
molecules in the respective transfected cells. For lower expressed
genes the excess is even larger. With such an excess of MBs, it is
likely that there are enough MBs in the majority of the cells to
measure the desired mRNA even if some variance in transfection
is expected.
Lipid and dendrimer-based oligonucleotide delivery methods,
have often failed to deliver MBs into cells. MB-transfection agent
complexes do not always dissociate efficiently once internalized,
leading to brightly fluorescing punctate aggregates that interfere
with fluorescent measurements. Furthermore, MB-transfection
agent complexes can often lead to entrapment and degradation
of the probes within endosome/lysosome compartments, thus
increasing background signal. The transfection efficiency of neu-
rons is particularly limited (Karra and Dahm, 2010), and indeed
LUHMES represent a particularly challenging system, since they
cannot be transfected using standard methods, such as lipo- or
nucleofection. One routinely usedmethod for direct introduction
of MBs into the cytoplasmic compartment of living cells is toxin-
based membrane permeabilization using streptolysin-O (SLO),
as used in this study. Although it has been successfully used to
deliver MBs into a wide variety of cell types, including human
dermal fibroblasts, stem cells, and cancer cells (Chen et al., 2011),
SLO is not a popular method for neuronal transfection. Here we
show that the SLO-membrane permeabilization delivery method
is a rapid, efficient, and gentle method for the delivery of MBs
into neuronal cells. Cells viability was high and the transfection
efficiency nearly 100%.
In conclusion, MBs offer significant advantages over tradi-
tional techniques because they allow for real-time imaging of
individual cells and preserve spatial information. In contrast to
PCR-based assays, which collect data from the differentiating
population as a whole, MBs accurately measure expression of
genes of interest on a single cell level. MBs can be used to repeat-
edly assess gene expression in the same cell population over time,
which is not possible using the destructive methods. Moreover,
they overcome the need to lyse cells for qRT-PCR, or fix cells for
molecular imaging techniques such FISH. Time-consuming and
technically challenging genetic manipulations are furthermore
not required.
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